Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeroen Claus

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Oncotargets and Therapy|August 13, 2013
Update on imatinib for gastrointestinal stromal tumors: duration of treatmentMark Linch, Jeroen Claus, Charlotte Benson
Biochemical Society Transactions|July 19, 2013
Pseudokinase drug intervention: a potentially poisoned chaliceJeroen Claus, Angus J M Cameron, Peter J Parker
Biochemical Society Transactions|August 12, 2014
A role for the pseudokinase HER3 in the acquired resistance against EGFR- and HER2-directed targeted therapyJeroen Claus, Gargi Patel, Tony Ng, et al.
Biochemical Society Transactions|November 18, 2014
Regulation of the cytokinesis cleavage furrow by PKCεNicola Brownlow, Tanya Pike, Victoria Crossland, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2010
Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysisPeter Nagy, Jeroen Claus, Thomas M Jovin, et al.
Cell|December 8, 2023
An oncogenic phenoscape of colonic stem cell polarizationXiao Qin, Ferran Cardoso Rodriguez, Jahangir Sufi, et al.
Methods in Enzymology|May 7, 2022
Targeting the HER3 pseudokinase domain with small molecule inhibitorsAudrey Colomba, Jeroen Claus, Forson Gao, et al.
Biochemical Society Transactions|January 24, 2014
Functional implications of assigned, assumed and assembled PKC structuresMark Linch, Philippe Riou, Jeroen Claus, et al.
Bio-Protocol|September 17, 2021
Cluster Analysis of Endogenous HER2 and HER3 Receptors in SKBR3 CellsSelene K Roberts, Michael Hirsch, Alexandra McStea, et al.
Cell|December 8, 2023
Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responsesMaría Ramos Zapatero, Alexander Tong, James W Opzoomer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Oncotargets and Therapy|August 13, 2013
Update on imatinib for gastrointestinal stromal tumors: duration of treatmentMark Linch, Jeroen Claus, Charlotte Benson
Biochemical Society Transactions|July 19, 2013
Pseudokinase drug intervention: a potentially poisoned chaliceJeroen Claus, Angus J M Cameron, Peter J Parker
Biochemical Society Transactions|August 12, 2014
A role for the pseudokinase HER3 in the acquired resistance against EGFR- and HER2-directed targeted therapyJeroen Claus, Gargi Patel, Tony Ng, et al.
Biochemical Society Transactions|November 18, 2014
Regulation of the cytokinesis cleavage furrow by PKCεNicola Brownlow, Tanya Pike, Victoria Crossland, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2010
Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysisPeter Nagy, Jeroen Claus, Thomas M Jovin, et al.
Cell|December 8, 2023
An oncogenic phenoscape of colonic stem cell polarizationXiao Qin, Ferran Cardoso Rodriguez, Jahangir Sufi, et al.
Methods in Enzymology|May 7, 2022
Targeting the HER3 pseudokinase domain with small molecule inhibitorsAudrey Colomba, Jeroen Claus, Forson Gao, et al.
Biochemical Society Transactions|January 24, 2014
Functional implications of assigned, assumed and assembled PKC structuresMark Linch, Philippe Riou, Jeroen Claus, et al.
Bio-Protocol|September 17, 2021
Cluster Analysis of Endogenous HER2 and HER3 Receptors in SKBR3 CellsSelene K Roberts, Michael Hirsch, Alexandra McStea, et al.
Cell|December 8, 2023
Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responsesMaría Ramos Zapatero, Alexander Tong, James W Opzoomer, et al.
Pageof 2